RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Neonatal Technology Development Consortium

Company

Content

History

2024: Creation of a consortium

In August 2024, it became known that a new consortium was created in Russia aimed at developing advanced neonatal technology. Within its framework, the efforts of leading industrial, medical and educational institutions of the Sverdlovsk region will be combined. The consortium is headed by the Ural Optical and Mechanical Plant named after E.S. Yalamov (UOMZ), which is part of the Shvabe holding.

According to Rostec, 19 organizations have joined the consortium, including the Ural Federal University named after the first President of Russia B.N. Yeltsin, the Ural State Medical University, as well as a number of leading medical institutions in the region. The main goal of the collaboration is to create a new neonatal technique that will meet world standards and contribute to improving medical care for newborns.

A consortium has been created in Russia to develop neonatal technology

General Director of UOMZ Anatoly Sludnykh emphasized the importance of integrating scientific, educational and technological potential to achieve significant results in healthcare.

File:Aquote1.png
Close cooperation of scientists, doctors and engineers allows us to introduce advanced technologies into the health care system, which helps save children's lives both in Russia and abroad, he said.
File:Aquote2.png

The consortium sets itself ambitious tasks, including the development of innovative equipment for neonatal centers and the improvement of existing technologies. The main emphasis will be placed on the creation of equipment that can replace foreign analogues and ensure maximum effectiveness in the treatment of newborns.

The work of the consortium covers a wide range of areas: from the design of new equipment to joint research in the field of functional geometry of the heart of newborns and adults, the development of innovative materials for medical needs, as well as the search for promising medicines for the treatment of cancer.[1]

Notes